UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Aromatase inhibitors in early hormone receptor-positive breast cancer - What is the optimal initiation time for the maximum benefit?

Needleman, SJ; Tobias, JS; (2008) Aromatase inhibitors in early hormone receptor-positive breast cancer - What is the optimal initiation time for the maximum benefit? DRUGS , 68 (1) pp. 1-15. 10.2165/00003495-200868010-00001.

Full text not available from this repository.
Type: Article
Title: Aromatase inhibitors in early hormone receptor-positive breast cancer - What is the optimal initiation time for the maximum benefit?
DOI: 10.2165/00003495-200868010-00001
Keywords: Science & Technology, Life Sciences & Biomedicine, Pharmacology & Pharmacy, Toxicology, FIRST-LINE THERAPY, POSTMENOPAUSAL WOMEN, RANDOMIZED-TRIAL, ADJUVANT TAMOXIFEN, ESTROGEN-RECEPTOR, ENDOCRINE THERAPY, PROGESTERONE-RECEPTOR, SURVIVAL ANALYSIS, ARNO-95 TRIAL, DOUBLE-BLIND
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > UCL Medical School
URI: http://discovery.ucl.ac.uk/id/eprint/1492523
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item